A skin cancer testing company formerly known as DermTech, Inc. has agreed to settle allegations that it violated the False Claims Act by knowingly submitting false claims for unreliable skin cancer tests to the Medicare program. DermTech is now liquidating as DTech Liquidating Inc. after filing for Chapter 11 bankruptcy in the District of Delaware in June 2024. As part of the resolution announced today, the United States received an Allowed Class Three General Unsecured Claim of $5,038,011 in the bankruptcy proceeding.
Source: U.S. Department of Justice